Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Blood Cancer Journal, Published online: 13 April 2023; doi:10.1038/s41408-023-00826-6Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 13, 2023 Category: Hematology Authors: Warren Fiskus Christopher P. Mill Christine Birdwell John A. Davis Kaberi Das Steffen Boettcher Tapan M. Kadia Courtney D. DiNardo Koichi Takahashi Sanam Loghavi Michael J. Soth Tim Heffernan Gerard M. McGeehan Xinjia Ruan Xiaoping Su Christopher R. Vakoc Source Type: research
Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study
Blood Cancer Journal, Published online: 13 April 2023; doi:10.1038/s41408-023-00825-7Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 13, 2023 Category: Hematology Authors: Jiahua Niu Huiying Qiu Fang Xiang Lin Zhu Jun Yang Chongmei Huang Kun Zhou Yin Tong Yu Cai Baoxia Dong Yuan Lu Xuedong Sun Liping Wan Xueying Ding Haopeng Wang Xianmin Song Source Type: research
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms
Blood Cancer Journal, Published online: 11 April 2023; doi:10.1038/s41408-023-00821-xTP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 11, 2023 Category: Hematology Authors: Mithun Vinod Shah Elizabeth Ngoc Hoa Tran Syed Shah Rakchha Chhetri Anmol Baranwal Dariusz Ladon Carl Shultz Aref Al-Kali Anna L. Brown Dong Chen Hamish S. Scott Patricia Greipp Daniel Thomas Hassan B. Alkhateeb Deepak Singhal Naseema Gangat Sharad Kumar Source Type: research
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
Blood Cancer Journal, Published online: 10 April 2023; doi:10.1038/s41408-023-00818-6Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 10, 2023 Category: Hematology Authors: Aref Al-Kali Ahmad Nanaa David Viswanatha Rong He Phuong Nguyen Dragan Jevremovic James M. Foran Cecelia Arana Yi Patricia T. Greipp Naseema Gangat Mrinal Patnaik Ayalew Tefferi Mark R. Litzow Abhishek A. Mangaonkar Mithun Vinod Shah Talha Badar Hassan B. Source Type: research
Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
Blood Cancer Journal, Published online: 10 April 2023; doi:10.1038/s41408-023-00824-8Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 10, 2023 Category: Hematology Authors: Ahmad Alcheikh Griffith B. Perkins Phillippa A. Pucar Amelia Cecchin Cheng Sheng Chai Matthew Tunbridge Anouschka Akerman Anupriya Aggarwal Vanessa Milogiannakis Stuart Turville Sharon Allen Pravin Hissaria Tatjana Banovic P. Toby Coates David M. Ross Source Type: research
E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma
Blood Cancer Journal, Published online: 07 April 2023; doi:10.1038/s41408-023-00828-4E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 7, 2023 Category: Hematology Authors: Mina Maksimos Barbara Muz John L. Magnani Abdel Kareem Azab Source Type: research
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma
Blood Cancer Journal, Published online: 05 April 2023; doi:10.1038/s41408-023-00820-yPrognostic value of early bone marrow MRD status in CAR-T therapy for myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 5, 2023 Category: Hematology Authors: Radhika Bansal Mizba Baksh Jeremy T. Larsen Matthew A. Hathcock David Dingli A. Keith Stewart Prashant Kapoor Taxiarchis Kourelis Suzanne R. Hayman Rahma M. Warsame Rafael Fonseca P. Leif Bergsagel Sikander Ailawadhi Shaji K. Kumar Yi Lin Source Type: research
Multiple myeloma with acute light chain cast nephropathy
Blood Cancer Journal, Published online: 29 March 2023; doi:10.1038/s41408-023-00806-wMultiple myeloma with acute light chain cast nephropathy (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 29, 2023 Category: Hematology Authors: Nelson Leung S. Vincent Rajkumar Source Type: research
Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study
Blood Cancer Journal, Published online: 24 March 2023; doi:10.1038/s41408-023-00816-8Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 24, 2023 Category: Hematology Authors: Fen Saj Yadav Nisha Prasanth Ganesan Smita Kayal Rakhee Kar Dhanapathi Halanaik Biswajit Dubashi Source Type: research
CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study
Blood Cancer Journal, Published online: 24 March 2023; doi:10.1038/s41408-023-00813-xCD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 24, 2023 Category: Hematology Authors: Jiahua Niu Huiying Qiu Fang Xiang Lin Zhu Jun Yang Chongmei Huang Kun Zhou Yin Tong Yu Cai Baoxia Dong Yuan Lu Xuedong Sun Liping Wan Xueying Ding Haopeng Wang Xianmin Song Source Type: research
ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias
Blood Cancer Journal, Published online: 23 March 2023; doi:10.1038/s41408-023-00810-0ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 23, 2023 Category: Hematology Authors: Konstantin Golovine Gleb Abalakov Zhaorui Lian Srinivas Chatla Adam Karami Kumaraswamy Naidu Chitrala Jozef Madzo Margaret Nieborowska-Skorska Jian Huang Tomasz Skorski Source Type: research
Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma
Blood Cancer Journal, Published online: 23 March 2023; doi:10.1038/s41408-023-00817-7Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 23, 2023 Category: Hematology Authors: Marietheres Evers Martin Schreder Thorsten St ühmer Franziska Jundt Regina Ebert Tanja Nicole Hartmann Michael Altenbuchinger Martina Rudelius Martin Kuric Wyonna Darleen Rindt Torsten Steinbrunn Christian Langer Sofia Catalina Heredia-Guerrero Hermann E Source Type: research
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
Blood Cancer Journal, Published online: 22 March 2023; doi:10.1038/s41408-023-00804-yClinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 22, 2023 Category: Hematology Authors: Noopur Raje Mar ía-Victoria Mateos Shinsuke Iida Donna Reece Source Type: research
Multiple myeloma with t(11;14): impact of novel agents on outcome
Blood Cancer Journal, Published online: 20 March 2023; doi:10.1038/s41408-023-00807-9Multiple myeloma with t(11;14): impact of novel agents on outcome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 20, 2023 Category: Hematology Authors: Borja Puertas Ver ónica González-Calle Eduardo Sobejano-Fuertes Fernando Escalante Beatriz Rey-Bua Irene Padilla Ram ón García-Sanz Noemi Puig Norma C. Guti érrez Mar ía-Victoria Mateos Source Type: research
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Blood Cancer Journal, Published online: 20 March 2023; doi:10.1038/s41408-023-00814-wCorrection: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 20, 2023 Category: Hematology Authors: S æmundur Rögnvaldsson Thorvardur Jon Love Sigrun Thorsteinsdottir El ín Ruth Reed J ón Þórir Óskarsson Íris Pétursdóttir Gu ðrún Ásta Sigurðardóttir Brynjar Vi ðarsson P áll Torfi Önundarson Bjarni A. Agnarsson Margr ét Sigurðardótti Source Type: research
